About the Journal
Types or Articles
About CAR T Cells
Frequently Asked Questions (FAQ)
The Review
Contact Us
Search
Global Statistics
About the Journal
Types or Articles
About CAR T Cells
Frequently Asked Questions (FAQ)
The Review
Contact Us
Search
Regulatory Updates
AACR
ASCO
ASH
Business & Economics
Clinical Trial Updates
Conference Coverage
Contract Development an Manufacturing
Editorial
EHA
ESMO
Expert Interviews
Guidelines
Health Insurance
Manufacturing
News
Opinion
Peer Reviewed
Phase 1 Trials
Phase 2 Trials
Phase 3 Trials
Preclinical
Reviews
Science
Regulatory Updates
Novel CAR T-Cell Therapy for Neuroendocrine Cancer Receives FDA Fast Track Designation
CHM-2101, an autologous Cadherin 17 (CDH17) Chimeric Antigen Receptor (CAR-) T-cell therapy for the treatment of advanced gastrointestinal (GI) cancers that are relapsed or...
Peter Hofland
-
June 5, 2025
Recent Articles
‘Eureka Moment’ in Tumor Treatment: Nearly One in Five People Diagnosed with Cancer wiling to Choose an Innovative Therapy
Business & Economics
November 11, 2025
SITC 2025: Macrophage-targeting CAR monocytes Improve Immunotherapy Outcomes in Breast Cancer
Conference Coverage
November 11, 2025
Jiahui International Cancer Center Successfully Treats a 78-year-old Patient from New Zealand with Advanced CAR T-Cell Therapy
News
November 10, 2025
SITC 2025: Results from the Phase 1 / 2a AERIAL Trial Evaluating Lateral CAR-T LEU011 for the Treatment of Solid Tumors
Conference Coverage
November 10, 2025
Pediatric Oncology: Novel Treatment Proves ‘Miracle’ for 6-Year-Old with Leukemia
News
November 10, 2025
Stay on op - Ge the daily news in your inbox
Subscribe